3 completed. 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Virosomes: new trials by email Literature Review of Virosomes trials Research Report on Virosomes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14) Inflexal V - Influenza | Phase 3 | Completed | Crucell Holland BV | 110 | 2013-07-01 | 2013-08-30 |
| Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains Inflexal V - Influenza | Phase 3 | Completed | Crucell Holland BV | 110 | 2012-07-01 | 2013-12-20 |
| Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania PEV 301& 302 in virosomes, Inflexal V (active comparator) - Falciparum Malaria | Phase 1 | Completed | Swiss Tropical & Public Health Institute | 50 | 2008-01-01 | 2013-03-15 |
Influenza, Human (2) · Virus Diseases (2) · Malaria (1) · Malaria, Falciparum (1)
Crucell Holland BV (2) · Swiss Tropical & Public Health Institute (1)
Switzerland (2) · Tanzania (1)
Blaise Genton, MD PhD (1) · Michael Seiberling, MD (1) · Milko Radicioni, MD (1)